Accessibility Menu
Terumo logo

Terumo(OTC) TRUMF

Current Price$12.76
Market Cap$18.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+57%
5 Year-31%
1 Year-20%
1 Month+0%
Terumo last closing stock price
MetricPriceDate
Last closeUSD 12.762026-07-24
Terumo stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.02%USD 12.892026-07-17
1 month+0.28%USD 12.732026-06-24
3 month+1.13%USD 12.622026-04-22
Year to date-2.37%USD 13.072025-12-31
1 year-20.16%USD 15.982025-07-24
3 year-14.28%USD 14.892023-07-25
5 year-30.97%USD 18.492021-07-23
Since inception+56.84%USD 8.142003-07-31

Terumo Financials at a Glance

Market Cap

$18.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥1.14T

Net Income (TTM)

¥136.61B

EPS (TTM)

$0.61

P/E Ratio

20.75

Dividend

$0.20

Beta (Volatility)

0.28 (Low)

Price

$12.76

Volume

255

Open

$12.76

Previous Close

$12.76

Daily Range

$12.76 - $12.76

52-Week Range

$11.49 - $20.46

Estimated Earnings Date

Aug 7, 2026

TRUMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Terumo

Terumo Corporation is a global medical technology company specializing in the development, manufacturing, and distribution of a wide array of healthcare products and equipment. Founded in 1921 and headquartered in Tokyo, Japan, Terumo operates across three key segments: Cardiac and Vascular, Medical Care Solutions, and Blood and Cell Technologies.

Products and Services
  • Cardiac and vascular products including stents and catheters
  • Medical care solutions such as syringes and infusion pumps
  • Blood and cell technologies for collection and processing
Growth Outlook
  • Revenue growth of 14.5% year-over-year in the latest quarter
  • Strong demand in the cardiac and vascular segment driving expansion
  • Investment in R&D to enhance product offerings and market reach
Financial Highlights
  • Latest quarterly revenue of JPY 302.2 billion, up from JPY 296.9 billion
  • Net income of JPY 26.5 billion, reflecting a 10.5% net profit margin
  • TTM operating cash flow of JPY 89.5 billion, indicating strong liquidity
Terumo Corporation has established itself as a leader in the medical technology sector, with a diverse product portfolio that addresses critical healthcare needs. The company's focus on innovation and quality has positioned it well for future growth, particularly in the cardiac and vascular markets. Recent financial performance highlights a robust revenue increase and solid profitability, underscoring the effectiveness of its operational strategies. With ongoing investments in research and development, Terumo is poised to continue expanding its market presence and enhancing its product offerings, making it an intriguing option for potential investors interested in the healthcare sector.
AI Generated • Jul 4, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

31,185

CEO

Hikaru Samejima, MBA

Website

www.terumo.co.jp

Headquarters

Tokyo, TY 151-0072, JP

TRUMF Financials

Key Financial Metrics (TTM)

Gross Margin

52.54%

Operating Margin

16.32%

Net Income Margin

12.01%

Return on Equity

9.19%

Return on Capital

9.18%

Return on Assets

5.88%

Earnings Yield

4.82%

Dividend Yield

1.53%

Payout Ratio

30.38%

Stock Overview

Market Cap

$18.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.48B

Volume

255

Avg. Volume

2.99K

Financials (TTM)

Gross Profit

¥597.85B

Operating Income

¥188.10B

EBITDA

¥280.94B

Operating Cash Flow

¥232.44B

Capital Expenditure

-¥85.71B

Free Cash Flow

¥146.73B

Cash & ST Invst.

¥282.26B

Total Debt

¥382.19B

Terumo Performance Analysis

Terumo annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31JPY 6,054,862,693-3.3%
20242024-03-31JPY 6,383,499,4035.4%
20252025-03-31JPY 6,796,776,0386.5%
20262026-03-31JPY 7,511,190,78610.5%
Terumo sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-1.5%
Q22025-09-307.3%
Q32025-12-316.5%
Q42026-03-311.8%
Terumo annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31JPY 0.44-15.9%
20242024-03-31JPY 0.4912.7%
20252025-03-31JPY 0.524.7%
20262026-03-31JPY 0.6118.0%
Terumo sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30128.0%
Q22025-09-30-15.4%
Q32025-12-31-8.5%
Q42026-03-31-19.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

¥302.21B

+14.5%

Gross Profit

¥149.96B

+8.2%

Gross Margin

49.62%

N/A

Market Cap

$18.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$603.65K

N/A

Employees

31,185

N/A

Net Income

¥26.53B

+44.5%

EBITDA

¥61.02B

-5.1%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

¥282.26B

+27.0%

Total Debt

¥382.19B

+118.6%

Accounts Receivable

¥218.94B

+23.8%

Inventory

¥337.75B

+14.7%

Long Term Debt

¥100.54B

-37.1%

Short Term Debt

¥281.65B

+1777.7%

Return on Assets

5.88%

N/A

Return on Invested Capital

10.43%

N/A

Free Cash Flow

¥54.08B

+32.5%

Operating Cash Flow

¥89.47B

+34.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SAUHFStraumann Holding AG
$118.30-2.99%
SDMHFSartorius Stedim Biotech S.A.
$193.00+0.52%
SAUHYStraumann Holding AG
$11.64-1.02%
SUVPFSartorius AG
$256.25+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About TRUMF

What is the current price of Terumo?

Terumo is trading at $12.76 per share.

What is the 52-week range for Terumo?

Over the past 52 weeks, Terumo has traded between $11.49 and $20.46.

How much debt does Terumo have?

As of the most recent reporting period, Terumo reported total debt of ¥2.69B.

How much cash does Terumo have on hand?

Terumo reported ¥1.76B in cash and cash equivalents in its most recent financial results.

What is Terumo’s dividend yield?

Terumo currently has a dividend yield of 1.53%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services